|
|
OTC Healthcare in Japan to 2013
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 201 Pages | |||||||||
| Inhalt der Studie: |
Introduction
This databook provides key data and information on the OTC healthcare market in Japan. This report is a comprehensive resource for market, category and segment level data including value.....
Introduction This databook provides key data and information on the OTC healthcare market in Japan. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share. Scope *Contains information on:analgesics,medicated skin product,topical OTC,traditional,indigestion,cough&cold,plasters&Bandages,vitamins and first aid kits *Market,category and segment level information on value with historic (2003-2008) and forecast (2009-2013) data *Category level company and brand share as well as distribution share information for 2007 and 2008 *Review of the top two companies within the OTC healthcare market, including company overview, key facts and business description Highlights The market for OTC healthcare in Japan increased at a compound annual growth rate of 2.2% between 2003 and 2008. The traditional medicines category led the OTC healthcare market in Japan, accounting for a share of 32.1%. Leading players in Japanese OTC healthcare market include Johnson & Johnson, Kracie Holdings, Ltd and Novartis AG. Reasons to Purchase *Develop business strategies by understanding the quantitative trends within the OTC healthcare market in Japan *Design effective marketing and sales strategies by identifying key market categories and segments *Identify key players within the market to plan lucrative M&A, partnerships and agreements Report Highlights [Studien Infos ausblenden] |
|||||||||||
|
TABLE OF CONTENTS Chapter 1 Executive Summary 2 Summary market level: OTC healthcare 2 Summary category level: analgesics 3 Summary category level: topical OTC medicines 4 Summary category level: cough and cold preparations 5 Summary category level: indigestion preparations 6 Summary category level: medicated skin products 7 Summary category level: first aid kits 8 Summary category level: other OTC healthcare products 9 Summary category level: plasters & bandages 10 Summary category level: traditional medicines 11 Summary category level: vitamins and minerals 12 Chapter 2 Introduction 13 What is this report about? 13 How to use this report 13 Market definition 14 Chapter 3 Market Overview 33 Value analysis (Yen), 2003?08 33 Value analysis (Yen), 2008?13 35 Value analysis (US dollars), 2003?08 38 Value analysis (US dollars), 2008?13 39 Company and brand share analysis 41 Distribution analysis 48 Chapter 4 Leading Company Profiles 50 Johnson & Johnson 50 Kracie Holdings, Ltd. 52 Chapter 5 Category Analysis: Analgesics 54 Value analysis (Yen), 2003?08 54 Value analysis (Yen), 2008?13 55 Value analysis (US dollars), 2003?08 57 Value analysis (US dollars), 2008?13 57 Company and brand share analysis 59 Distribution analysis 62 Chapter 6 Category Analysis: Topical OTC Medicines 64 Value analysis (Yen), 2003?08 64 Value analysis (Yen), 2008?13 65 Value analysis (US dollars), 2003?08 67 Value analysis (US dollars), 2008?13 68 Company and brand share analysis 70 Distribution analysis 73 Chapter 7 Category Analysis: Cough and Cold Preparations 75 Value analysis (Yen), 2003?08 75 Value analysis (Yen), 2008?13 76 Value analysis (US dollars), 2003?08 78 Value analysis (US dollars), 2008?13 79 Company and brand share analysis 81 Distribution analysis 85 Chapter 8 Category Analysis: Indigestion Preparations 87 Value analysis (Yen), 2003?08 87 Value analysis (Yen), 2008?13 88 Value analysis (US dollars), 2003?08 90 Value analysis (US dollars), 2008?13 90 Company and brand share analysis 92 Distribution analysis 96 Chapter 9 Category Analysis: Medicated Skin Products 98 Value analysis (Yen), 2003?08 98 Value analysis (Yen), 2008?13 99 Value analysis (US dollars), 2003?08 101 Value analysis (US dollars), 2008?13 102 Company and brand share analysis 104 Distribution analysis 107 Chapter 10 Category Analysis: First Aid Kits 109 Value analysis (Yen), 2003?08 109 Value analysis (Yen), 2008?13 110 Value analysis (US dollars), 2003?08 111 Value analysis (US dollars), 2008?13 111 Company and brand share analysis 112 Distribution analysis 115 Chapter 11 Category Analysis: Other OTC Healthcare Products 117 Value analysis (Yen), 2003?08 117 Value analysis (Yen), 2008?13 118 Value analysis (US dollars), 2003?08 120 Value analysis (US dollars), 2008?13 121 Company and brand share analysis 123 Distribution analysis 128 Chapter 12 Category Analysis: Plasters & Bandages 130 Value analysis (Yen), 2003?08 130 Value analysis (Yen), 2008?13 131 Value analysis (US dollars), 2003?08 133 Value analysis (US dollars), 2008?13 134 Company and brand share analysis 136 Distribution analysis 139 Chapter 13 Category Analysis: Traditional Medicines 141 Value analysis (Yen), 2003?08 141 Value analysis (Yen), 2008?13 142 Value analysis (US dollars), 2003?08 143 Value analysis (US dollars), 2008?13 143 Company and brand share analysis 144 Distribution analysis 148 Chapter 14 Category Analysis: Vitamins and Minerals 150 Value analysis (Yen), 2003?08 150 Value analysis (Yen), 2008?13 151 Value analysis (US dollars), 2003?08 153 Value analysis (US dollars), 2008?13 153 Company and brand share analysis 155 Distribution analysis 158 Chapter 15 Country Comparison 160 Value 160 Market share 164 Chapter 16 PESTLE analysis 165 Summary 165 Political analysis 166 Economic analysis 169 Social analysis 173 Technological analysis 177 Legal analysis 182 Environmental analysis 186 Chapter 17 New Product Development 190 Product launches over time 190 Recent product launches 192 Chapter 18 Macroeconomic Profile 193 Macroeconomic indicators 193 Chapter 19 Research Methodology 198 Methodology overview 198 Secondary research 199 Market modeling 200 Creating an initial data model 200 Revising the initial data model 200 Creating a final estimate 201 Creating demographic value splits 201 Primary research 201 Data finalization 202 Ongoing research 202 Chapter 20 APPENDIX 203 Future readings 203 How to contact experts in your industry 203 Disclaimer 203 LIST OF FIGURES Figure 1: Japan OTC healthcare value and value forecast, 2003?13 (JPYm, nominal prices) 35 Figure 2: Japan OTC healthcare category growth comparison, by value, 2003?13 38 Figure 3: Japan OTC healthcare company share, by value, 2007?08 (%) 43 Figure 4: Japan OTC healthcare distribution channels, by value, 2007?08 (%) 47 Figure 5: Japan analgesics value and value forecast, 2003?13 (JPYm, nominal prices) 54 Figure 6: Japan analgesics category growth comparison, by value, 2003?13 56 Figure 7: Japan analgesics company share, by value, 2007?08 (%) 58 Figure 8: Japan analgesics distribution channels, by value, 2007?08 (%) 61 Figure 9: Japan topical OTC medicines value and value forecast, 2003?13 (JPYm, nominal prices) 64 Figure 10: Japan topical OTC medicines category growth comparison, by value, 2003?13 67 Figure 11: Japan topical OTC medicines company share, by value, 2007?08 (%) 69 Figure 12: Japan topical OTC medicines distribution channels, by value, 2007?08 (%) 72 Figure 13: Japan cough and cold preparations value and value forecast, 2003?13 (JPYm, nominal prices) 75 Figure 14: Japan cough and cold preparations category growth comparison, by value, 2003?13 78 Figure 15: Japan cough and cold preparations company share, by value, 2007?08 (%) 81 Figure 16: Japan cough and cold preparations distribution channels, by value, 2007?08 (%) 84 Figure 17: Japan indigestion preparations value and value forecast, 2003?13 (JPYm, nominal prices) 87 Figure 18: Japan indigestion preparations category growth comparison, by value, 2003?13 89 Figure 19: Japan indigestion preparations company share, by value, 2007?08 (%) 92 Figure 20: Japan indigestion preparations distribution channels, by value, 2007?08 (%) 95 Figure 21: Japan medicated skin products value and value forecast, 2003?13 (JPYm, nominal prices) 98 Figure 22: Japan medicated skin products category growth comparison, by value, 2003?13 101 Figure 23: Japan medicated skin products company share, by value, 2007?08 (%) 103 Figure 24: Japan medicated skin products distribution channels, by value, 2007?08 (%) 106 Figure 25: Japan first aid kits value and value forecast, 2003?13 (JPYm, nominal prices) 108 Figure 26: Japan first aid kits company share, by value, 2007?08 (%) 111 Figure 27: Japan first aid kits distribution channels, by value, 2007?08 (%) 114 Figure 28: Japan other OTC healthcare products value and value forecast, 2003?13 (JPYm, nominal prices) 117 Figure 29: Japan other OTC healthcare products category growth comparison, by value, 2003?13 120 Figure 30: Japan other OTC healthcare products company share, by value, 2007?08 (%) 123 Figure 31: Japan other OTC healthcare products distribution channels, by value, 2007?08 (%) 127 Figure 32: Japan plasters & bandages value and value forecast, 2003?13 (JPYm, nominal prices) 130 Figure 33: Japan plasters & bandages category growth comparison, by value, 2003?13 133 Figure 34: Japan plasters & bandages company share, by value, 2007?08 (%) 135 Figure 35: Japan plasters & bandages distribution channels, by value, 2007?08 (%) 138 Figure 36: Japan traditional medicines value and value forecast, 2003?13 (JPYm, nominal prices) 140 Figure 37: Japan traditional medicines company share, by value, 2007?08 (%) 144 Figure 38: Japan traditional medicines distribution channels, by value, 2007?08 (%) 147 Figure 39: Japan vitamins and minerals value and value forecast, 2003?13 (JPYm, nominal prices) 150 Figure 40: Japan vitamins and minerals category growth comparison, by value, 2003?13 152 Figure 41: Japan vitamins and minerals company share, by value, 2007?08 (%) 154 Figure 42: Japan vitamins and minerals distribution channels, by value, 2007?08 (%) 157 Figure 43: Global OTC healthcare market split (value terms, 2008), top five countries 159 Figure 44: Global OTC healthcare market value, 2003–08, top five countries 161 Figure 45: Annual data review process 197 LIST OF TABLES Table 1: OTC healthcare category definitions 15 Table 2: OTC healthcare distribution channels 17 Table 3: Japan OTC healthcare value, 2003?08 (JPYm, nominal prices) 32 Table 4: Japan OTC healthcare value forecast, 2008?13 (JPYm, nominal prices) 34 Table 5: Japan OTC healthcare value, 2003?08 ($m, nominal prices) 36 Table 6: Japan OTC healthcare value forecast, 2008?13 ($m, nominal prices) 37 Table 7: Japan OTC healthcare brand share, by value, 2007?08 (%) 39 Table 8: Japan OTC healthcare value, by brand 2007?08 (JPYm, nominal prices) 41 Table 9: Japan OTC healthcare company share by value, 2007?08 (%) 44 Table 10: Japan OTC healthcare value, by company, 2007?08 (JPYm, nominal prices) 45 Table 11: Japan OTC healthcare distribution channels, by value, 2007?08 (%) 46 Table 12: Japan OTC healthcare value, by distribution channel, 2007?08 (JPYm, nominal prices) 46 Table 13: Johnson & Johnson key facts 48 Table 14: Kracie Holdings, Ltd. key facts 50 Table 15: Japan analgesics value, 2003?08 (JPYm, nominal prices) 52 Table 16: Japan analgesics value forecast, 2008?13 (JPYm, nominal prices) 53 Table 17: Japan analgesics value, 2003?08 ($m, nominal prices) 55 Table 18: Japan analgesics value forecast, 2008?13 ($m, nominal prices) 55 Table 19: Japan analgesics brand share, by value, 2007?08 (%) 57 Table 20: Japan analgesics value, by brand 2007?08 (JPYm, nominal prices) 57 Table 21: Japan analgesics company share by value, 2007?08 (%) 59 Table 22: Japan analgesics value, by company, 2007?08 (JPYm, nominal prices) 59 Table 23: Japan analgesics distribution channels, by value, 2007?08 (%) 60 Table 24: Japan analgesics value, by distribution channel, 2007?08 (JPYm, nominal prices) 60 Table 25: Japan topical OTC medicines value, 2003?08 (JPYm, nominal prices) 62 Table 26: Japan topical OTC medicines value forecast, 2008?13 (JPYm, nominal prices) 63 Table 27: Japan topical OTC medicines value, 2003?08 ($m, nominal prices) 65 Table 28: Japan topical OTC medicines value forecast, 2008?13 ($m, nominal prices) 66 Table 29: Japan topical OTC medicines brand share, by value, 2007?08 (%) 68 Table 30: Japan topical OTC medicines value, by brand 2007?08 (JPYm, nominal prices) 68 Table 31: Japan topical OTC medicines company share by value, 2007?08 (%) 70 Table 32: Japan topical OTC medicines value, by company, 2007?08 (JPYm, nominal prices) 70 Table 33: Japan topical OTC medicines distribution channels, by value, 2007?08 (%) 71 Table 34: Japan topical OTC medicines value, by distribution channel, 2007?08 (JPYm, nominal prices) 71 Table 35: Japan cough and cold preparations value, 2003?08 (JPYm, nominal prices) 73 Table 36: Japan cough and cold preparations value forecast, 2008?13 (JPYm, nominal prices) 74 Table 37: Japan cough and cold preparations value, 2003?08 ($m, nominal prices) 76 Table 38: Japan cough and cold preparations value forecast, 2008?13 ($m, nominal prices) 77 Table 39: Japan cough and cold preparations brand share, by value, 2007?08 (%) 79 Table 40: Japan cough and cold preparations value, by brand 2007?08 (JPYm, nominal prices) 80 Table 41: Japan cough and cold preparations company share by value, 2007?08 (%) 82 Table 42: Japan cough and cold preparations value, by company, 2007?08 (JPYm, nominal prices) 82 Table 43: Japan cough and cold preparations distribution channels, by value, 2007?08 (%) 83 Table 44: Japan cough and cold preparations value, by distribution channel, 2007?08 (JPYm, nominal prices) 83 Table 45: Japan indigestion preparations value, 2003?08 (JPYm, nominal prices) 85 Table 46: Japan indigestion preparations value forecast, 2008?13 (JPYm, nominal prices) 86 Table 47: Japan indigestion preparations value, 2003?08 ($m, nominal prices) 88 Table 48: Japan indigestion preparations value forecast, 2008?13 ($m, nominal prices) 88 Table 49: Japan indigestion preparations brand share, by value, 2007?08 (%) 90 Table 50: Japan indigestion preparations value, by brand 2007?08 (JPYm, nominal prices) 91 Table 51: Japan indigestion preparations company share by value, 2007?08 (%) 93 Table 52: Japan indigestion preparations value, by company, 2007?08 (JPYm, nominal prices) 93 Table 53: Japan indigestion preparations distribution channels, by value, 2007?08 (%) 94 Table 54: Japan indigestion preparations value, by distribution channel, 2007?08 (JPYm, nominal prices) 94 Table 55: Japan medicated skin products value, 2003?08 (JPYm, nominal prices) 96 Table 56: Japan medicated skin products value forecast, 2008?13 (JPYm, nominal prices) 97 Table 57: Japan medicated skin products value, 2003?08 ($m, nominal prices) 99 Table 58: Japan medicated skin products value forecast, 2008?13 ($m, nominal prices) 100 Table 59: Japan medicated skin products brand share, by value, 2007?08 (%) 102 Table 60: Japan medicated skin products value, by brand 2007?08 (JPYm, nominal prices) 102 Table 61: Japan medicated skin products company share by value, 2007?08 (%) 104 Table 62: Japan medicated skin products value, by company, 2007?08 (JPYm, nominal prices) 104 Table 63: Japan medicated skin products distribution channels, by value, 2007?08 (%) 105 Table 64: Japan medicated skin products value, by distribution channel, 2007?08 (JPYm, nominal prices) 105 Table 65: Japan first aid kits value, 2003?08 (JPYm, nominal prices) 107 Table 66: Japan first aid kits value forecast, 2008?13 (JPYm, nominal prices) 108 Table 67: Japan first aid kits value, 2003?08 ($m, nominal prices) 109 Table 68: Japan first aid kits value forecast, 2008?13 ($m, nominal prices) 109 Table 69: Japan first aid kits brand share, by value, 2007?08 (%) 110 Table 70: Japan first aid kits value, by brand 2007?08 (JPYm, nominal prices) 110 Table 71: Japan first aid kits company share by value, 2007?08 (%) 112 Table 72: Japan first aid kits value, by company, 2007?08 (JPYm, nominal prices) 112 Table 73: Japan first aid kits distribution channels, by value, 2007?08 (%) 113 Table 74: Japan first aid kits value, by distribution channel, 2007?08 (JPYm, nominal prices) 113 Table 75: Japan other OTC healthcare products value, 2003?08 (JPYm, nominal prices) 115 Table 76: Japan other OTC healthcare products value forecast, 2008?13 (JPYm, nominal prices) 116 Table 77: Japan other OTC healthcare products value, 2003?08 ($m, nominal prices) 118 Table 78: Japan other OTC healthcare products value forecast, 2008?13 ($m, nominal prices) 119 Table 79: Japan other OTC healthcare products brand share, by value, 2007?08 (%) 121 Table 80: Japan other OTC healthcare products value, by brand 2007?08 (JPYm, nominal prices) 122 Table 81: Japan other OTC healthcare products company share by value, 2007?08 (%) 124 Table 82: Japan other OTC healthcare products value, by company, 2007?08 (JPYm, nominal prices) 125 Table 83: Japan other OTC healthcare products distribution channels, by value, 2007?08 (%) 126 Table 84: Japan other OTC healthcare products value, by distribution channel, 2007?08 (JPYm, nominal prices) 126 Table 85: Japan plasters & bandages value, 2003?08 (JPYm, nominal prices) 128 Table 86: Japan plasters & bandages value forecast, 2008?13 (JPYm, nominal prices) 129 Table 87: Japan plasters & bandages value, 2003?08 ($m, nominal prices) 131 Table 88: Japan plasters & bandages value forecast, 2008?13 ($m, nominal prices) 132 Table 89: Japan plasters & bandages brand share, by value, 2007?08 (%) 134 Table 90: Japan plasters & bandages value, by brand 2007?08 (JPYm, nominal prices) 134 Table 91: Japan plasters & bandages company share by value, 2007?08 (%) 136 Table 92: Japan plasters & bandages value, by company, 2007?08 (JPYm, nominal prices) 136 Table 93: Japan plasters & bandages distribution channels, by value, 2007?08 (%) 137 Table 94: Japan plasters & bandages value, by distribution channel, 2007?08 (JPYm, nominal prices) 137 Table 95: Japan traditional medicines value, 2003?08 (JPYm, nominal prices) 139 Table 96: Japan traditional medicines value forecast, 2008?13 (JPYm, nominal prices) 140 Table 97: Japan traditional medicines value, 2003?08 ($m, nominal prices) 141 Table 98: Japan traditional medicines value forecast, 2008?13 ($m, nominal prices) 141 Table 99: Japan traditional medicines brand share, by value, 2007?08 (%) 142 Table 100: Japan traditional medicines value, by brand 2007?08 (JPYm, nominal prices) 143 Table 101: Japan traditional medicines company share by value, 2007?08 (%) 145 Table 102: Japan traditional medicines value, by company, 2007?08 (JPYm, nominal prices) 145 Table 103: Japan traditional medicines distribution channels, by value, 2007?08 (%) 146 Table 104: Japan traditional medicines value, by distribution channel, 2007?08 (JPYm, nominal prices) 146 Table 105: Japan vitamins and minerals value, 2003?08 (JPYm, nominal prices) 148 Table 106: Japan vitamins and minerals value forecast, 2008?13 (JPYm, nominal prices) 149 Table 107: Japan vitamins and minerals value, 2003?08 ($m, nominal prices) 151 Table 108: Japan vitamins and minerals value forecast, 2008?13 ($m, nominal prices) 151 Table 109: Japan vitamins and minerals brand share, by value, 2007?08 (%) 153 Table 110: Japan vitamins and minerals value, by brand 2007?08 (JPYm, nominal prices) 153 Table 111: Japan vitamins and minerals company share by value, 2007?08 (%) 155 Table 112: Japan vitamins and minerals value, by company, 2007?08 (JPYm, nominal prices) 155 Table 113: Japan vitamins and minerals distribution channels, by value, 2007?08 (%) 156 Table 114: Japan vitamins and minerals value, by distribution channel, 2007?08 (JPYm, nominal prices) 156 Table 115: Global OTC healthcare market value, 2008 158 Table 116: Global OTC healthcare market split (value terms ($m), 2008), top five countries 161 Table 117: Leading players, top five countries 162 Table 118: Analysis of Japan’s Political landscape 164 Table 119: Analysis of Japan’s economy 167 Table 120: Analysis of Japan’s social system 171 Table 121: Analysis of Japan’s technology landscape 175 Table 122: Average annual salaries for researchers across countries 177 Table 123: Japan’s R&D expenditure 178 Table 124: R&D personnel in Japan, 2002–12 179 Table 125: Analysis of Japan’s legal landscape 180 Table 126: Analysis of Japan’s environmental landscape 184 Table 127: Japan OTC healthcare new product launches reports, by company (top five companies), 2008 188 Table 128: Japan OTC healthcare new product launches SKUs, by company (top five companies), 2008 188 Table 129: Japan OTC healthcare new product launches (reports), by flavor and fragrances (top 10 flavors), 2008 189 Table 130: Japan OTC healthcare new product launches (reports), by ingredients (top 10 ingredients), 2008 189 Table 131: Japan OTC healthcare new product launches (reports), by package tags or claims (top 10 claims), 2008 190 Table 132: Japan OTC healthcare new product launches - recent five launches 2008 190 Table 133: Japan population, by age group, 2003?08 (millions) 191 Table 134: Japan population forecast, by age group, 2008?13 (millions) 192 Table 135: Japan population, by gender, 2003?08 (millions) 192 Table 136: Japan population forecast, by gender, 2008?13 (millions) 193 Table 137: Japan nominal GDP, 2003?08 (JPYbn, nominal prices) 193 Table 138: Japan nominal GDP forecast, 2008?13 (JPYbn, nominal prices) 193 Table 139: Japan real GDP, 2003?08 (JPYbn, 2000 prices) 194 Table 140: Japan real GDP forecast, 2008?13 (JPYbn, 2000 prices) 194 Table 141: Japan real GDP, 2003?08 ($bn, 2000 prices) 194 Table 142: Japan real GDP forecast, 2008?13 ($bn, 2000 prices) 195 Table 143: Japan consumer price index, 2003?08 (2000=100) 195 Table 144: Japan consumer price index, 2008?13 (2000=100) 195 [Inhaltsverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||


